News

Pharmabiz1h

Pilatus Biosciences inks clinical trial collaboration with Roche to evaluate PLT012 in first-in-human study in hepatocellular carcinoma

Pilatus Biosciences inks clinical trial collaboration with Roche to evaluate PLT012 in first-in-human study in hepatocellular carcinoma: Epalinges, Switzerland Saturday, August 16 ...
Pharmabiz2h

Vyome Therapeutics receives Nasdaq Stock Market approval to merge with ReShape Lifesciences

Vyome Therapeutics receives Nasdaq Stock Market approval to merge with ReShape Lifesciences: Cambridge, Massachusetts Saturday, August 16, 2025, 17:00 Hrs [IST] Vyome Therapeutics ...
Pharmabiz11h

Gujarat FDCA-ONDCP discuss illegal production and export of narcotic & habit-forming drugs

Gujarat FDCA-ONDCP discuss illegal production and export of narcotic & habit-forming drugs: Shardul Nautiyal, Mumbai Saturday ...
Pharmabiz3h

Study reveals how small changes in walking technique may help treat knee osteoarthritis

Study reveals how small changes in walking technique may help treat knee osteoarthritis: New York Saturday, August 16, 2025, 16:00 Hrs [IST] Gait analysis and pain measures show t ...
Pharmabiz4h

AleraCare, PURE Healthcare enter into merger agreement to enhance availability of infusion services

AleraCare, PURE Healthcare enter into merger agreement to enhance availability of infusion services: Phoenix Saturday, August 16, 2025, 15:00 Hrs [IST] AleraCare, a leading provid ...
Pharmabiz5h

Leads Biolabs completes patient enrollment in pivotal trial of Opamtistomig monotherapy for extrapulmonary neuroendocrine carcinoma

Leads Biolabs completes patient enrollment in pivotal trial of Opamtistomig monotherapy for extrapulmonary neuroendocrine carcinoma: Nanjing, China Saturday, August 16, 2025, 14:0 ...
Pharmabiz6h

Basilea Pharma enters licensing pact with Venatorx Pharma to acquire rights to ceftibuten-ledaborbactam etzadroxil, a clinical phase 3-ready oral BL/BLI combo to treat cUTI

Basilea Pharma enters licensing pact with Venatorx Pharma to acquire rights to ceftibuten-ledaborbactam etzadroxil, a clinical phase 3-ready oral BL/BLI combo to treat cUTI Allschwil, Switzerland ...
Pharmabiz7h

ScaleReady awards multiple G-Rex grants to leading investigators at the USC and CHLA

ScaleReady awards multiple G-Rex grants to leading investigators at the USC and CHLA: St. Paul, Minnesota Saturday, August 16, 2025, 12:00 Hrs [IST] ScaleReady in collaboration wi ...
Pharmabiz10h

EMA grants orphan designation to Sanofi’s rilzabrutinib, a reversible covalent BTK inhibitor, for IgG4-related disease

EMA grants orphan designation to Sanofi’s rilzabrutinib, a reversible covalent BTK inhibitor, for IgG4-related disease: Paris Saturday, August 16, 2025, 09:00 Hrs [IST] Sanofi a ...
Pharmabiz8h

Aquestive announces $75 mn strategic funding agreement with RTW Investments to support the potential launch of Anaphylm sublingual film

Aquestive announces $75 mn strategic funding agreement with RTW Investments to support the potential launch of Anaphylm sublingual film: Warren, New Jersey Saturday, August 16, 20 ...
Pharmabiz11h

Chennai to host IDMA's NEC and TN chapter's AGM at Fortune Beach Resort on Aug 16

Chennai to host IDMA's NEC and TN chapter's AGM at Fortune Beach Resort on Aug 16: Peethaambaran Kunnathoor, Chennai Saturday, August 16, 2025, 08:00 Hrs [IST] The National Execut ...
Pharmabiz9h

HKBU develops Microfluidic Flow Cytomolecular Analyser to promote extensive application of precision medicine

HKBU develops Microfluidic Flow Cytomolecular Analyser to promote extensive application of precision medicine: Kowloon, Hong Kong Saturday, August 16, 2025, 10:00 Hrs [IST] Testin ...